(Q45722354)

15 December 2017

title

Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells (English)

1 reference

15 December 2017

C-T Yang

1

1 reference

15 December 2017

J Song

2

1 reference

15 December 2017

X Bu

3

1 reference

15 December 2017

Y-S Cong

4

1 reference

15 December 2017

S Bacchetti

5

1 reference

15 December 2017

P Rennie

6

1 reference

15 December 2017

W W-G Jia

7

1 reference

15 December 2017

publication date

1 August 2003

1 reference

15 December 2017

1 reference

15 December 2017

volume

10

1 reference

15 December 2017

issue

17

1 reference

15 December 2017

page(s)

1494-1502

1 reference

HSV as a gene transfer vector for the nervous system

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Development and application of herpes simplex virus vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Conditionally replicating herpes vectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Relative activity and specificity of promoters from prostate-expressed genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Regulation of herpesvirus macromolecular synthesis V. Properties of α polypeptides made in HSV-1 and HSV-2 infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

21 January 2018

Herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Regulation of herpes simplex virus 1 genes: alpha gene sequence requirements for transient induction of indicator genes regulated by beta or late (gamma 2) promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Polymerase chain reaction-based enzyme immunoassay for quantitation of telomerase activity: application to colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Herpes simplex virus type 1-based amplicon vector systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Magnesium-dependent association and folding of oligonucleosomes reconstituted with ubiquitinated H2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Risk factors for pre-cancerous lesions of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Relationship of stable integration of herpes simplex virus-2 Bg/II N subfragment Xho2 to malignant transformation of human papillomavirus-immortalized cervical keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

The cause of invasive cervical cancer could be multifactorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Activation of the cellular transcription factor AP-1 in herpes simplex virus infected cells is dependent on the viral immediate-early protein ICPO

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

ICP0, a regulator of herpes simplex virus during lytic and latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for transcriptional activation of immediate early promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Herpes simplex virus triggers and then disarms a host antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

A tale of two trials: selectively replicating herpesviruses for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Toxicity studies in thymidine kinase-deficient herpes simplex virus therapy for malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Herpes simplex virus ICP0 mutants are hypersensitive to interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

Transcriptional targeting of herpes simplex virus for cell-specific replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Evidence that herpes simplex virus DNA is transcribed by cellular RNA polymerase B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Cofactors with human papillomavirus in a population-based study of vulvar cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Herpes simplex virus immediate-early proteins ICP0 and ICP4 activate the endogenous human alpha-globin gene in nonerythroid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

The repressing and enhancing functions of the herpes simplex virus regulatory protein ICP27 map to C-terminal regions and are required to modulate viral gene expression very early in infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302005

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302005

1 reference

Dimensions Publication ID

15 December 2017

1016723591

0 references

1 reference